SAN FRANCISCO (MarketWatch) -- Thoratec Corp. said Monday that the Phase I trial for its HeartMate II left ventricular assist system showed there were no device-related deaths, no pump failures ...

The HeartMate 3 is considered the safest mechanical heart pump of its kind, but a federal database contains more than 4,500 reports in which it may have caused or contributed to a patient's death.

Abbott has launched a “first-of-its-kind” trial to identify advanced heart failure patients who could potentially benefit from early advanced therapy options, namely HeartMate 3 left ...

Nexteer Automotive debuts three Driveline technologies engineered to meet the unique demands of EVs, as well as premium driving experiences across all propulsion types. These next-generation ...

The BrioVAD pump is around 20% smaller than the HeartMate 3 and has a slightly narrower driveline, the cable that runs from the pump through the skin to the battery pack worn outside the body.

Abbott has issued a recall for select HeartMate mobile power units used with its HeartMate3 and HeartMate III left-ventricular assist systems due to risk of sudden power loss that could lead to ...

Newly released data by Chicago-based Abbott shows that its HeartMate 3 heart pump does just what he dreamed of: the left ventricular assist device (LVAD) extends survival by at least five years ...

Abbott Laboratories, Inc. ABT recently announced that the FDA has approved a change of label for its HeartMate 3 left ventricular assist device (LVAD or heart pump). The development, meant ...

The HeartMate 3's predecessor, the HeartMate II, was priced similarly to the HeartWare. But design enhancements in the HeartMate 3 have led to lower rates of post-surgical complications.

WebMD explains how a left ventricular assist device -- also called an LVAD -- can help a heart weakened by heart failure.

HeartMate II is smaller and easier to implant than prior FDA-approved devices, and with only one moving part, it is designed to provide exceptional reliability and improved patient quality of life.

NEW ORLEANS, LA—Final, full results from the MOMENTUM 3 trial show that the HeartMate 3 magnetically levitated, centrifugal-flow left ventricular assist device (LVAD) is superior to the ...